Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype

(2010) G Kristiansen et al.   BRITISH JOURNAL OF CANCER

Principles and challenges of genome-wide DNA methylation analysis

(2010) Peter W. Laird   NATURE REVIEWS GENETICS

Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme

(2010) Katan Patel et al.   NUCLEIC ACIDS RESEARCH

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2009) B. T. Hennessy et al.   CANCER RESEARCH

Methylation not a frequent “second hit” in tumors with germline BRCA mutations

(2009) Amy M. Dworkin et al.   Familial Cancer

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

(2009) Elgene Lim et al.   NATURE MEDICINE

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer

(2008) K. P. M. Suijkerbuijk et al.   ANNALS OF ONCOLOGY

Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells

(2008) Takashi Kumagai et al.   INTERNATIONAL JOURNAL OF CANCER

Genome-scale DNA methylation maps of pluripotent and differentiated cells

(2008) Alexander Meissner et al.   NATURE